Induction of a SOS repair system in lysogenic bacteria by zearalenone and its prevention by vitamin E

Chemico-Biological Interactions

Volumn 113, Issue 1, 1998, Pages 15-25

  Ghedira Chekir L ^a   Maaroufi, K ^a   Zakhama, A ^b   Ellouz, F ^a   Dhouib, S ^a   Creppy, E E ^c   Bacha, H ^a  

^a Lab Biochim de Toxicologie Molec   (France)

^b Rue Avicenne 5019   (France)

^c UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Lysogenic bacteria; SOS repair system induction; Vitamin E; Zearalenone

Indexed keywords

ALPHA TOCOPHEROL; OXYGEN RADICAL; ZEARALENONE;

ARTICLE; BACTERICIDAL ACTIVITY; CYTOTOXICITY; DNA DAMAGE; DNA REPAIR; ESCHERICHIA COLI; GENOTOXICITY; LIPID PEROXIDATION; MUTAGENIC ACTIVITY; NONHUMAN;

ANIMALS; ANTIOXIDANTS; BACTERIOPHAGE LAMBDA; DNA REPAIR; ESCHERICHIA COLI; FREE RADICAL SCAVENGERS; HUMANS; LYSOGENY; MICE; RATS; SOS RESPONSE (GENETICS); VIRUS ACTIVATION; VITAMIN E; ZEARALENONE;

BACILLUS SUBTILIS; BACTERIA (MICROORGANISMS); FUSARIUM;

EID: 0345337282     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-2797(98)00013-1     Document Type: Article

References (36)

1. Bennet G.A., Shotwel O.L. Zearalenone in cereals grains. J. Am. Oil Chem. Soc. 56:1979;812-819.
2. Sutton J.C., Balik W., Funnett H.S. Relation of weather variables to incidence of zearalenone in corn in Southern Ontario. Can. J. Lant. Sci. 60:1980;149-155.
3. Trenholm H.L., Thompson B.K., Standish J.F., Seamen W.L. Mycotoxins in feeds and feedstuffs. Scott P.M., Tranholm H.L., Sutton M.D. Mycotoxins: A Canadian Perspective. 1985;43-49 National Research Council of Canada, Ottawa, Ont. 22848.
4. Kim J.C., Kang H.J., Lee D.H., Lee Y.W., Yoshizawa T. Natural occurrence of Fusarium mycotoxins (trichothecenes and zearalenone) in barley and corn in Korea. Appl. Environ. Microbiol. 59:1993;3798-3802.
5. Yuwai K.E., Rao K.L., Singh K., Tanaka T., Ueno Y. Occurrence of nivalenol, deoxynivalenol and zearalenone in imported cereals in Papua New Guinea. Natural Toxins. 2:1994;19-21.
6. Boyd P., Wittliff J. Mechanism of Fusarium mycotoxin action in mammary gland. J. Toxicol. Environ. Health. 4p:1978;1-8.
7. Kiang D.T., Kennedy B.J., Lathre S.V., Mirocha C.J. Binding characteristics of zearalenone analogues to estrogens receptors. Cancer Res. 38:1978;3611-3615.
8. Greenman D.L., Metha R.G., Wittliff J.L. Nuclear interactions of Fusarium mycotoxins with estradiol binding sites in the mouse uterus. J. Toxicol. Environ. Health. 5:1979;593-598.
9. Powell-Jones W., Raeford S., Lucier G.W. Binding properties of zearalenone mycotoxins to hepatic estrogen receptors. Mol. Pharmacol. 20:1981;35-42.
10. Kitagawa M., Tashiro F., Ueno Y. Interaction between zearalenone, an estrogenic mycotoxin and the estrogen receptor of the rat brain. Proc. Jpn. Assoc. Mycotoxicol. 15:1982;28-30.
11. Etienne M., Jemmali M. Effects of Zearalenone (F2) on oestrus activity and reproduction in gilt. J. Anim. Sci. 55:1982;1-10.
12. H. Bacha, L. Chekir, F. Ellouz, R. Hadidane, E.E. Creppy, Effect of zearalenone on fertilisation and gestation in rats, in: K.A. Scudanore (Ed.), Occurrence and Significance of Mycotoxins, Proceedings of a UK Workshop, Central Science Laboratory, 1993, pp. 258-262.
13. Maaroufi K., Chekir L., Creppy E.E., Ellouz F., Bacha H. Zearalenone induces modifications of haematological and biochemical parameters in rats. Toxicon. 34:1996;535-540.
14. Kiessling K.H., Pettersson H. Metabolism of zearalenone in rat liver. Acta Pharmacol. Toxicol. 43:1978;285-290.
15. Mirocha C.J., Pathre S.V., Robinson T.S. Comparative metabolism of zearalenone and transmission into bovine milk. Food Cosmet. Toxicol. 19:1981;25-30.
16. Ueno Y., Ayakis S., Sato N., Ito T. Fate and mode of action of zearalenone. Ann. Nutr. Alim. 31:1977;935-948.
17. Hidy P.H., Baldwin R.S., Greasham R.L., Keith C.L., Mc Mullen J.R. Zearalenone and some derivatives: production and biological activities. Adv. Appl. Microbiol. 22:1977;59-82.
18. US Food and Drug Administration, Foods and Drugs, US Code Federal Regulations, Title 21, Part 522, 1980, pp. 192 and 239.
19. Kuiper-Goodman T., Scott P.M., Watanabe H. Risk assessment of the mycotoxin zearalenone. Reg. Toxicol. Pharmacol. 7:1987;253-306.
20. U. Thrane, Fusarium species and their specific profiles of secondary metabolites, in: J. Chelkowski (Ed.), Fusarium Mycotoxins, Taxonomy and Pathogenicity, Elsevier, Amsterdam, 1989, pp. 199-225.
21. IARC (International Agency for Research on Cancer), Some naturally occurring substances: food items and constituents, heterocyclic aromatic amines and mycotoxins, in: IARC Monographs on the Evaluations of the Carcinogenic Risk of Chemicals to Humans, vol. 56, IARC, Lyon, 1993, pp. 397-444.
22. Etienne M., Dourmad J.Y. Effects of zearalenone or glucosinolates in the diet on reproduction in sows: a review. Livestock Prod. Sci. 40:1994;99-113.
23. Miksicek R.J. Interactions of naturally occurring non steroidal estrogens with expressed recombinant human estrogen receptor. J. Steroid Biochem. Mol. Biol. 49:1994;153-160.
24. Ueno Y., Kubota K. DNA attacking ability of carcinogenic mycotoxins in recombination-deficient mutant cells of Bacillus subtilis. Cancer Res. 36:1976;445-451.
25. Thust R., Kneist S., Huhne V. Genotoxicity of Fusarium mycotoxins (nivalenol, fusarenon-X, T2-toxin, and zearalenone) in Chinese hamster V79-E cells in vitro. Arch. Geschwulsforsch. 53:1983;9-15.
26. Galloway S.M., Amstrong M.J., Reuben C., Colman S., Brown B., Cannon C., Bloom A.D., Nakamura F., Ahmed M., Duk S., Rimpo J., Margolin B.H., Resnick M.A., Anderson B., Zeiger E. Chromosome aberrations and sister chromatid exchanges in Chinese hamster ovary cells: evaluation of 108 chemicals. Environ. Mol. Mutagen. 10:1987;1-175.
27. Pfohl-Leszkowicz A., Chékir-Ghédira L., Bacha H. Genotoxicity of zearalenone, an oestrogenic mycotoxin: DNA adduct formation in female mouse tissues. Carcinogenesis. 16:1995;2315-2320.
28. Miller E.C., Miller J.A. Searches for ultimate chemical carcinogens and their reactions with cellular macromolecules. Cancer. 47:1981;2327-2345.
29. Beland F.A., Kadlubar F.F. Formation and persistence of arylamine DNA adducts in vivo. Environ. Health Perspect. 62:1985;19-33.
30. Poirier M.C., Beland F.A. DNA adduct measurements a tumour incidence during carcinogen exposure in animals models: implications for DNA adduct-based human cancer risk assessment. Chem. Res. Toxicol. 5:1992;749-755.
31. Li D., Wang Y.M., Nath R.G., Mistry S., Randerath K. Modulation by dietary Vitamin E of I-compounds (putative indigenous DNA modifications) in rat liver and kidney. J. Nutr. 12:1991;65-71.
32. Grosse Y., Chékir-Ghédira L., Huc A., Obrecht-Pflumio S., Dirheimer G., Bacha H., Pfohl-Leszkowicz A. Retinol, ascorbic acid and α-tocopherol prevent DNA adduct formation in mice treated with the mycotoxins ochratoxin A and zearalenone. Cancer Lett. 114:1997;225-229.
33. T. Hyunh, R. Young, R. Davis, Constructing and screening cDNA libraries in l gt 10 and l gt 11, in: D. Glover (Ed.), DNA Cloning: A Practical Approach, IRL Press, Oxford, 1984.
34. Boyer H.W., Roulland-Dussoix D. A complementation analysis of the restriction and modification of DNA in a Escherichia coli. J. Mol. Biol. 41:1969;459-472.
35. G.D. Davis, M.D. Dibner, J.F. Battey, Preparation of l gt 10 and l gt 11 in cDNA cloning vectors, in: L.G. Davis (Ed.), Basic Methods in Molecular Biology, Elsevier, New York, 1986, pp. 194-198.
36. S.C. Gad, C.S. Neil, Statistics for toxicologists, in: W. Hayes, C.S. Neil, (Eds.), Principles and Methods of Toxicology, Raven Press, New York, 1982, pp. 273-308.